News and Publishing Service for Cannabis Related, Canadian Companies
Contact us:
905.674.5977
twitter
facebook
linkedin
News and Publishing Service for Cannabis Related, Canadian Companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
Cannabis News
Lexaria Bioscience Corp. (LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming Investigational New Drug
Lift Toronto 2023 Cannabis Conference & Expo Promises to Energize, Inspire, Educate, and Motivate Audiences
NECANN’s New York Cannabis & Hemp Convention Set to Empower the Cannabis Industry
BizCann Expo: An Elite Business & Networking Event for All Things Cannabis
Alternative Products Expo: Innovation and Sustainability
CannabisNewsBreaks
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Upcoming $1.6M Registered Direct Offering
Lexaria Bioscience Corp. (LEXX)
September 29, 2023
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces New Studies to Examine DehydraTECH(TM)-Powered GLP-1 Drugs
Lexaria Bioscience Corp. (LEXX)
September 21, 2023
CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) New Subsidiary Maximizing Patented DehydraTECH(TM) in Various Markets
Lexaria Bioscience Corp. (LEXX)
September 15, 2023
CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets
Lexaria Bioscience Corp. (LEXX)
September 8, 2023
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference
InMed Pharmaceuticals Inc. (INM)
September 7, 2023
View More CannabisNewsBreaks
CanadianCannabisWire Articles
Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Advancing its DehydraTECH(TM) Technology, Having Demonstrated its Potential Across Multiple Areas of Application
Lexaria Bioscience Corp. (LEXX)
September 29, 2023
Lexaria Bioscience Corp. (NASDAQ: LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming Investigational New Drug Application Submission
Lexaria Bioscience Corp. (LEXX)
September 21, 2023
Lexaria Bioscience Corp. (NASDAQ: LEXX) is On Track for IND Application with the FDA for its Planned U.S. Phase 1b Hypertension Clinical Trial
Lexaria Bioscience Corp. (LEXX)
September 15, 2023
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Investigational Research Programs Position the Company for Important Partnership Opportunities and Growth
Lexaria Bioscience Corp. (LEXX)
September 12, 2023
NECANN’s New York Cannabis & Hemp Convention Set to Empower the Cannabis Industry
NECANN
September 5, 2023
View All CanadianCannabisWire Articles
CannabisNewsAudio
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expanding its Footprint in the Booming Legal Marijuana Market
Wildflower Brands Inc. (WLDFF)
April 26, 2019
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Set to Profit from CBD Market Growth via Recent Distribution Agreements
Wildflower Brands Inc. (WLDFF)
April 12, 2019
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Ideally Positioned as the Healing Power of CBD Gains Awareness
Wildflower Brands Inc. (WLDFF)
March 29, 2019
CannabisNewsAudio – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Poised to Benefit from Soaring CBD Market
Wildflower Brands Inc. (WLDFF)
March 25, 2019
CannabisNewsAudio – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Positioned to Benefit from the Rise of CBD Beverages
Phivida Holdings Inc. (PHVAF)
March 22, 2019
View All CannabisNewsAudio
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Medical Marijuana
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
CanadianCannabisWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
905.674.5977